Document is current
Any future updates will be listed below
-
Authors
Roydhouse, Jessica https://orcid.org/0000-0002-8025-5841
Henson, Glen J. https://orcid.org/0000-0002-1237-5710
Abdu, Nizam https://orcid.org/0000-0001-5103-687X
Dinh, Thi Thu Ngan https://orcid.org/0000-0003-2339-2628
Tran, Thi Ly https://orcid.org/0009-0005-6945-7396
Mulhern, Brendan
Campbell, Julie A.
-
Funding
Funding for this research was provided by:
Pfizer
University of Tasmania
- License Information
-
More Information
Article History
Received: 20 June 2025
Accepted: 15 February 2026
First Online: 4 March 2026
Declarations
:
: This study was funded by Pfizer, Inc. The sponsor did not have any role in the decision to submit for publication.
: Jessica Roydhouse has received consultancy funding from Gilead Sciences, Inc. and from the University of Birmingham Enterprise (UK), in the form of contracts between her institution, the University of Tasmania and these organisations. These consultancies are unrelated to this work. Jessica Roydhouse is an Editor-in-Chief of Quality of Life Research . This role is unrelated to this work. Glen J. Henson, Nizam Abdu, Thi Thu Ngan Dinh, Thi Ly Tran, Brendan Mulhern and Julie A. Campbell have no conflicts of interest that are directly relevant to the content of this article.
: As this study is a systematic review of published literature, ethics approval was not required.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: JR, GJH, TTND, BM and JAC had the idea for the article. TTND performed the literature search. JR, GJH, NA, TTND, TLT and JAC reviewed and/or extracted data from articles. JR drafted the work and GJH, NA, TTND, TLT, BM and JAC critically revised the work.
